Boston Scientific (BSX)

SG&A Expenses

$7.16B

TTM · Period ending: · USD

BSX logo

BSX SG&A Expenses

Latest reported$7.16B
BSX TTM SG&A Expenses ($0.00 → $7.16B)
High-resolution chart · PNG

BSX sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Boston Scientific SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
894,000,000
878,000,000
867,000,000
855,000,000
859,000,000
849,000,000
842,000,000
893,400,000
859,700,000
844,000,000
815,600,000
772,200,000
757,000,000
731,100,000
696,900,000
833,000,000
795,700,000
755,600,000
719,100,000
667,200,000
604,400,000
551,600,000
505,000,000
234,700,000
195,700,000
157,800,000
127,200,000
126,300,000
127,900,000
130,200,000
131,200,000
126,300,000
120,500,000
112,700,000
105,900,000
78,800,000
51,000,000
24,900,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.